Variants of RTP4 have additionally been implicated in diseases ranging from primary Sjogren’s syndrome to cutaneous melanoma, and it has been demonstrated to have a pro-inflammatory effect in neuroinvasive infections [30,39–41]. This evidence concerns the gene RTP4 and Sjogren syndrome.